Home / Stocks / PLX

PLX insider trading

Protalix BioTherapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
2
Bought · 24 mo
$308k
Buys · last 90 days
0 · $0
Most recent buy
2025-12-23

Recent insider filings

FiledInsiderTypeSharesPriceValue
2025-12-23Bashan Dror
PRESIDENT AND CEO
Bought56,000$1.81$101k
2025-08-12Schwartz Aharon
Director
Bought129,000$1.60$206k

Most active insider buyers

InsiderRoleBuysTotal bought
Schwartz AharonDirector1$206k
Bashan DrorPRESIDENT AND CEO1$101k

See PLX on the chart

Every insider buy and sell for PLX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.